0001055726-23-000033.txt : 20230516
0001055726-23-000033.hdr.sgml : 20230516
20230516164847
ACCESSION NUMBER: 0001055726-23-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230513
FILED AS OF DATE: 20230516
DATE AS OF CHANGE: 20230516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DANSEY ROGER D
CENTRAL INDEX KEY: 0001741836
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14888
FILM NUMBER: 23928323
MAIL ADDRESS:
STREET 1: 21823 30TH DRIVE SE
CITY: BOTHELL
STATE: WA
ZIP: 98021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INOVIO PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001055726
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330969592
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8584103134
MAIL ADDRESS:
STREET 1: 6769 MESA RIDGE RD.
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: INOVIO BIOMEDICAL CORP
DATE OF NAME CHANGE: 20050404
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL CORP
DATE OF NAME CHANGE: 20011116
FORMER COMPANY:
FORMER CONFORMED NAME: GENETRONICS BIOMEDICAL LTD
DATE OF NAME CHANGE: 19980213
4
1
wk-form4_1684270114.xml
FORM 4
X0407
4
2023-05-13
0
0001055726
INOVIO PHARMACEUTICALS, INC.
INO
0001741836
DANSEY ROGER D
660 W. GERMANTOWN PIKE SUITE 110
PLYMOUTH MEETING
PA
19462
1
0
0
0
0
Common Stock
2023-05-13
4
M
0
12000
A
24000
D
Common Stock
2023-05-16
4
M
0
19000
A
43000
D
Restricted Stock Unit
2023-05-13
4
M
0
12000
0
D
Common Stock
12000
12000
D
Common Stock Options
0.77
2023-05-15
4
A
0
35000
0
A
2033-05-15
Common Stock
35000
35000
D
Restricted Stock Unit
2023-05-15
4
A
0
26000
0
A
Common Stock
26000
26000
D
Restricted Stock Unit
2023-05-16
4
M
0
19000
0
D
Common Stock
19000
0
D
Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares vested on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 16, 2023.
This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy.
Options to vest 100% on May 15, 2024.
Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024.
/s/ Roger Dansey
2023-05-16